E-Zines

Check out our free and informative ezines and sign up now

Sign Up

Held Oct. 10, 2006

To get the most out of every dollar spent on your next postmarketing study, you need to start with motivated investigators. (If you’ve got a stagnant or stalled study, there’s still time to save it. Read on.)

But surprisingly, the biggest investigator incentive isn’t more money.

Deploy the Top 3 Motivators for a Cost-Effective Postmarketing Study

Order now for a 90-minute audio CD/transcript led by Dr. Hugo Stephenson, author and president of strategic research and safety at Quintiles, the world’s largest provider of contract research services. Dr. Stephenson gives you practical study design tactics, and user-friendly forms that enable you to motivate study investigators by providing:

  1. Enhanced patient benefits for trial participants
  2. Increased immediate scientific value of the study
  3. Lowered investigator workload, enabling the investigator to spend more time with his/her patients

And with so much at stake in postmarketing trials — from cost-sensitive study budgets to pending legislation in Congress, threatening greater trial scrutiny — any positive impact you can make to your existing or upcoming postmarketing study makes more sense now than ever before.

Let Dr. Stephenson show you how to deliver your next postmarketing study on schedule, when you:

  • Streamline the registration process. Use this plain-language registration form to reduce site paperwork and follow-up phone calls
  • Create long-term studies that increase immediate scientific value across study lifespan
  • Develop a structure for sites with no EC or IRC in place. Use this simplified, IRB-approved form for multiple sites
  • Employ the use of “pseudo-sites” to recruit patients quickly and reduce investigator workload, without going through ethics/IRB process
  • Simplify the randomization process when you perform by site, with or without crossover
  • Plan proactively for market effects on investigator motivation
  • Harness the right technology to initiate and maintain staff training for more reliable data
  • Capture clean data with workable strategies for developing case report forms
  • Design workflow-focused data capture procedures to maximize efficiency
  • Implement patient follow-up procedures that minimize investigator on-site time
  • Initiate proven strategies to revive a stalled study, including patient incentives
  • And more

Case Studies Offer Surprising and Effective Postmarketing Study Strategies

Order now and discover:

  • How you may be able to eliminate the randomization process
  • Surprising recommendations about electronic data capture (EDC)
  • How to revive a stagnant postmarketing study
  • How MSLs and sales reps can enhance your study’s effectiveness
  • And more
Meet Your Instructor

Hugo Stephenson, MD is president of strategic research and safety at Quintiles, the largest provider of contract research services in the world. Dr. Stephenson is responsible for Quintiles’s Phase IIIB, Phase IV and drug safety activities worldwide, which have included some of the pharmaceutical industry’s most challenging safety and post-approval studies. He is the author of Strategic Research: A Practical Handbook for Phase IIIB and Phase IV Clinical Studies.

Who Will Benefit?

This audio CD/transcript is a must for positions in drug, biotech, biologic and device companies, including:

  • Project managers
  • Clinical leads
  • Clinical research associates
  • Medical affairs
  • Health outcomes
  • Pharmacoepidemiology & risk management
  • Data management & statistics
  • Regulatory/legislative affairs professionals

Audio CD/transcript - Oct. 10, 2006